Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis

被引:0
|
作者
Affara, NI [1 ]
Robertson, FM [1 ]
机构
[1] Ohio State Univ, Dept Mol Virol, Columbus, OH 43210 USA
来源
IN VIVO | 2004年 / 18卷 / 05期
关键词
Akt/protein kinase B; anti-angiogenic drugs; inositidylphosphate-3-kinase (IP3-K); pericytes; platelet-derived growth factor beta; (PDGF beta); platelet-derived growth factor receptor beta; (PDGFR-beta); review; splice variant; angiogenesis; vascular_endothelial cells; vascular endothelial growth factor (VEGF); vascular targeting;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This review focuses on vascular endothelial growth factors (VEGF), a group of structurally-related proteins that serve as key growth factors for tumor-associated angiogenesis. Pathways induced by VEGF proteins that regulate biological functions of key cell types involved in tumor angiogenesis, including vascular endothelial cells, pericytes and tumor cells, are discussed. Strategies that are currently being developed and tested based on the emerging definitions of the roles of the multiple cell types involved in tumor vessel development, their selective production of VEGF-related proteins and other pro-angiogenic growth factors, their expression of associated receptors as well as identification of signal transduction pathways involved in VEGF-induced tumor survival and tumor-associated angiogenesis will be reviewed.
引用
收藏
页码:525 / 542
页数:18
相关论文
共 50 条